Loading...
•
Mar 31, 2020
Orthofix Q1 2020 Earnings Report
Orthofix reported a decrease in net sales but an increase in net income and EPS compared to the prior year period.
Key Takeaways
Orthofix Medical Inc. reported a decrease in net sales by 3.9% to $104.8 million for the first quarter ended March 31, 2020. However, the company's diluted earnings per share (EPS) was $1.32, and adjusted EPS was $0.09. The company proactively responded to COVID-19 challenges to ensure balance sheet and capital liquidity.
Net sales decreased by 3.9% compared to the prior year, reaching $104.8 million.
Diluted earnings per share (EPS) was $1.32, while adjusted EPS was $0.09.
Gross profit decreased to $81.4 million, with a gross margin of 77.7%.
The company borrowed $100.0 million against its secured revolving credit facility to navigate the uncertain macro-environment.
Orthofix
Orthofix
Orthofix Revenue by Segment
Revenue by Segment
Bone Growth Therapies Revenue
CapyFin.comSpinal Implants, Biologics and Enabling Technologies Revenue
CapyFin.comGlobal Spine Revenue
CapyFin.com Forward Guidance
Due to the uncertainty related to the COVID-19 pandemic, Orthofix is not providing quantitative guidance for the second quarter of 2020 or for the full year at this time.
Revenue & Expenses
Visualization of income flow from segment revenue to net income